Cargando…
miR-34a Inhibits Cell Proliferation by Targeting SATB2 in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the most common type of malignancy of the liver and has been reported as the third most frequent cause of cancer associated death worldwide. Accumulating evidence showed that the expression of miR-34a was abnormal in HCC patients; however, the role of miR-34a in HCC...
Autores principales: | Wu, Gang, Li, Zhixi, Wang, Youyu, Ju, Xueming, Huang, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304654/ https://www.ncbi.nlm.nih.gov/pubmed/30627547 http://dx.doi.org/10.1155/2018/2863902 |
Ejemplares similares
-
miR-34s inhibit osteoblast proliferation and differentiation in the mouse by targeting SATB2
por: Wei, Jianwen, et al.
Publicado: (2012) -
lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC
por: Li, Zhixi, et al.
Publicado: (2020) -
miR-211 suppresses hepatocellular carcinoma by downregulating SATB2
por: Jiang, Guixing, et al.
Publicado: (2015) -
miR-3666 suppresses cellular proliferation and invasion in colorectal cancer by targeting SATB2
por: Yang, Daqing, et al.
Publicado: (2018) -
miR-449a inhibits colorectal cancer progression by targeting SATB2
por: Sun, Xiaohua, et al.
Publicado: (2016)